---
title: "12 Health Care Stocks Moving In Monday's Intraday Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291831140.md"
description: "In Monday's intraday session, several healthcare stocks experienced significant volatility. Gainers included Innovative Eyewear (LUCY) up 95.4%, Seer (SEER) up 37.66%, and Bristol-Myers Squibb Celegne Rights (CELGR) up 33.37%. Conversely, notable losers were SL Science Holding (SLBT) down 23.2%, Basel Medical Group (BMGL) down 14.62%, and BioXcel Therapeutics (BTAI) down 14.5%. The report highlights specific price movements and market capitalizations for these listed entities."
datetime: "2026-07-06T17:05:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291831140.md)
  - [en](https://longbridge.com/en/news/291831140.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291831140.md)
generator: "portal-rs"
---

# 12 Health Care Stocks Moving In Monday's Intraday Session

### Gainers

-   **Innovative Eyewear** (NASDAQ:LUCY) stock moved upwards by 95.4% to $1.49 during Monday's regular session. The market value of their outstanding shares is at $4.8 million.
-   **Seer** (NASDAQ:SEER) shares rose 37.66% to $2.23. The company's market cap stands at $89.0 million.
-   **Bristol-Myers Squibb Company Celegne Contingent Value Rights** (NYSE:CELGR) stock increased by 33.37% to $0.12.
-   **YD Bio** (NASDAQ:YDES) stock rose 27.63% to $2.42. The market value of their outstanding shares is at $134.5 million.
-   **Axe Compute** (NASDAQ:AGPU) stock moved upwards by 20.5% to $8.53. The market value of their outstanding shares is at $76.5 million.
-   **Celularity** (NASDAQ:CELU) shares rose 19.95% to $0.74. The market value of their outstanding shares is at $17.6 million.

### Losers

-   **SL Science Holding** (NASDAQ:SLBT) stock decreased by 23.2% to $4.6 during Monday's regular session. The market value of their outstanding shares is at $3.3 billion.
-   **Basel Medical Group** (NASDAQ:BMGL) stock declined by 14.62% to $7.13. The market value of their outstanding shares is at $13.0 million.
-   **BioXcel Therapeutics** (NASDAQ:BTAI) stock declined by 14.5% to $1.18. The company's market cap stands at $42.6 million.
-   **Aktis Oncology** (NASDAQ:AKTS) shares fell 13.84% to $27.36. The market value of their outstanding shares is at $1.7 billion.
-   **Universe Pharmaceuticals** (NASDAQ:UPC) shares declined by 12.5% to $5.53. The company's market cap stands at $4.0 million.
-   **TransCode Therapeutics** (NASDAQ:RNAZ) stock decreased by 12.32% to $7.55. The company's market cap stands at $8.1 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [LUCY.US](https://longbridge.com/en/quote/LUCY.US.md)
- [BTAI.US](https://longbridge.com/en/quote/BTAI.US.md)
- [SLBT.US](https://longbridge.com/en/quote/SLBT.US.md)
- [SEER.US](https://longbridge.com/en/quote/SEER.US.md)
- [BMGL.US](https://longbridge.com/en/quote/BMGL.US.md)
- [BMY.US](https://longbridge.com/en/quote/BMY.US.md)
- [LUCYW.US](https://longbridge.com/en/quote/LUCYW.US.md)
- [YDES.US](https://longbridge.com/en/quote/YDES.US.md)
- [AGPU.US](https://longbridge.com/en/quote/AGPU.US.md)
- [CELU.US](https://longbridge.com/en/quote/CELU.US.md)
- [AKTS.US](https://longbridge.com/en/quote/AKTS.US.md)
- [UPC.US](https://longbridge.com/en/quote/UPC.US.md)
- [RNAZ.US](https://longbridge.com/en/quote/RNAZ.US.md)
- [YDESW.US](https://longbridge.com/en/quote/YDESW.US.md)
- [CELUW.US](https://longbridge.com/en/quote/CELUW.US.md)

## Related News & Research

- [17,077 Shares in Bristol Myers Squibb Company $BMY Purchased by Avaii Wealth Management LLC](https://longbridge.com/en/news/296315075.md)
- [Bristol Myers wins ‘milestone’ FDA approval of myeloma drug acquired from Celgene](https://longbridge.com/en/news/296131073.md)
- [LaSalle St. Investment Advisors LLC Takes $1.12 Million Position in Bristol Myers Squibb Company $BMY](https://longbridge.com/en/news/296603017.md)
- [North Dakota State Investment Board Boosts Holdings in Bristol Myers Squibb Company $BMY](https://longbridge.com/en/news/296020226.md)
- [Bristol Myers Squibb Gets FDA Nod For Novel Multiple Myeloma Treatment](https://longbridge.com/en/news/295957550.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**